Align Technology Inc header image

Align Technology Inc

ALGN

Equity

ISIN US0162551016 / Valor 1159441

NASDAQ (2024-11-19)
USD 222.58-3.18%

Align Technology Inc
UMushroom community rating:

star star star star star
4.50 2 votes No rating yet
NegativeNeutralPositive

About company

Align Technology Inc is a global leader in the dental CAD/CAM software market, offering fully integrated workflows to dental labs and practices through a wide network of partners and resellers in over 150 countries. The company's digital scanning technology, including the iTero intraoral scanner, complements its Invisalign system, enhancing patient scans and overall experience. Align Technology continues to invest in digital restorative workflows, with over 17 million restorative cases enabled by the iTero scanner to date. Additionally, the company provides a range of digitally enabled solutions for restorative dentistry, orthodontic treatment, and other dental applications. With a focus on innovation and customer satisfaction, Align Technology remains a leading provider of advanced clear aligner systems and digital orthodontic solutions worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (28.05.2024):

Q1'24 Revenue Growth

Align Technology Inc. reported a total revenue of $997.4 million in the first quarter of 2024, marking a 5.8% increase year-over-year. This growth includes a 3.5% increase in revenue from Clear Aligners and a significant 17.5% increase from Imaging Systems and CAD/CAM Services.

Q1'24 Earnings Per Share

For Q1'24, Align Technology Inc. achieved a diluted net income per share of $1.39. On a non-GAAP basis, the diluted net income per share was higher at $2.14, reflecting adjustments for certain non-recurring items.

Q1'24 Operating Income and Margin

Align Technology Inc. recorded an operating income of $154.1 million in Q1'24, with an operating margin of 15.5%. The non-GAAP operating margin was notably higher at 19.8%, indicating effective cost management and operational efficiency.

Q1'24 Clear Aligner Performance

The Clear Aligner segment of Align Technology Inc. generated revenues of $817.3 million in Q1'24, up 3.5% year-over-year. Additionally, the volume of Clear Aligner cases increased by 2.4% to 605.1 thousand cases during the quarter.

Q1'24 Imaging Systems and CAD/CAM Services

Align Technology Inc.'s Imaging Systems and CAD/CAM Services segment saw a robust revenue increase of 17.5% year-over-year, totaling $180.2 million in Q1'24. This growth highlights the strong demand and expanding market presence of Align's technology solutions in digital orthodontics and restorative dentistry.

Summarized from source with an LLMView Source

Key figures

7.71%1Y
-67.4%3Y
-18.0%5Y

Performance

38.3%1Y
52.4%3Y
53.4%5Y

Volatility

Market cap

17163 M

Market cap (USD)

Daily traded volume (Shares)

216,461

Daily traded volume (Shares)

1 day high/low

226.82 / 221.62

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.50

2 votes
Performance:
starstarstarstarstar
4.50
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.50
Nature:
starstarstarstarstar
4.00
Luba Schoenig
Switzerland, 29 May 2024
star star star star star
The market value of the dental aligners is set for fast growth
Lea Katunaric
Switzerland, 28 May 2024
star star star star star
Seems to be gaining interest and relevance as a beauty stock. I would keep an eye on it.

EQUITIES OF THE SAME SECTOR

HealthEquity Inc
HealthEquity Inc HealthEquity Inc Valor: 24679014
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 102.67
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 163.50
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.52%USD 314.17
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 33.75
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 27.48
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.85%USD 22.54
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.37%USD 21.82
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%USD 31.51
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.85%USD 49.01
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 29.68